Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 2 3

Status

Completed 9Terminated 4Recruiting 3Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Endocrine 1Breast 1

Conditions

Breast Neoplasms 305Carcinoma, Non-Small-Cell Lung 287Colorectal Neoplasms 159Prostatic Neoplasms 158Carcinoma, Hepatocellular 144Neoplasms 137Leukemia, Myeloid, Acute 131Lung Neoplasms 117Squamous Cell Carcinoma of Head and Neck 108Multiple Myeloma 104Triple Negative Breast Neoplasms 102Recurrence 101Pancreatic Neoplasms 96Stomach Neoplasms 94Ovarian Neoplasms 89Neoplasm Metastasis 87Lymphoma, Large B-Cell, Diffuse 81Sarcoma 70Esophageal Neoplasms 68Uterine Cervical Neoplasms 67Precursor Cell Lymphoblastic Leukemia-Lymphoma 67Melanoma 67Brain Neoplasms 67Rectal Neoplasms 64Head and Neck Neoplasms 62Glioblastoma 60Carcinoma, Renal Cell 58Myelodysplastic Syndromes 55Lymphoma 55Esophageal Squamous Cell Carcinoma 54

Interventions

fezolinetant 1Solifenacin Succinate 1Clonidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Hot Flashes × Clear all
NCT06957691 2026-03-09

Fezo-ADT

Brigham and Women's Hospital

Phase 2 Recruiting
60 enrolled
EndocrineGenitourinary

Adenocarcinoma, Prostatic Neoplasms, Multiple Endocrine Neoplasia Type 1, Hot Flashes

NCT01530373 2026-03-05

Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

University of Arkansas

Phase 2 Recruiting
110 enrolled
Breast

Breast Neoplasms, Hot Flashes

NCT06972875 2026-02-05

FLASH

University of Vermont

Phase 2 Recruiting
32 enrolled
Genitourinary

Prostatic Neoplasms, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡